SPL 1.08% 9.2¢ starpharma holdings limited

Ann: New clinical data for DEP cabazitaxel in prostate cancer, page-22

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. WBA
    2,384 Posts.
    lightbulb Created with Sketch. 422
    I just hope Astra Zeneca can do a lot better with 0446. Seems the most likely success story now abd the quickest route to licence deal.

    Interesting times for another BIO today. In TH ahead of CR to facilitate two new Insto investors.
 
watchlist Created with Sketch. Add SPL (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.